Skip to main content
. 2022 Sep 6;18(9):e1010463. doi: 10.1371/journal.pcbi.1010463

Table 2. Cases and deaths during the projection period in simulated scenarios.

Scenario Total Vaccines Additional Vaccines Cases Averted cases Averted cases (%) Deaths Averted Deaths Averted Deaths (%)
CAM AAM CAM vs baseline AAM vs CAM AAM vs baseline CAM vs baseline AAM vs CAM AAM vs baseline CAM AAM CAM vs baseline AAM vs CAM AAM vs baseline CAM vs baseline AAM vs CAM AAM vs baseline
Baseline 18,678,746 24,363,731 468,945
Minimal 10% vaccination 19,794,450 1,115,704 23,898,862 23,339,854 464,869 559,008 1,023,877 1.9 2.3 4.2 458,208 444,766 10,737 13,443 24,180 2.3 2.9 5.2
Minimal 20% vaccination 21,992,586 3,313,840 23,692,424 20,949,427 671,307 2,742,997 3,414,304 2.8 11.3 14.0 452,256 399,597 16,690 52,659 69,348 3.6 11.2 14.8
Minimal 26% vaccination 23,678,994 5,000,248 22,911,520 19,590,241 1,452,211 3,321,279 4,773,490 6.0 13.6 19.6 443,314 367,591 25,632 75,723 101,354 5.5 16.1 21.6
Allocation per recent cases 23,678,994 5,000,248 22,911,520 17,773,307 1,452,211 5,138,213 6,590,424 6.0 21.1 27.1 443,314 322,316 25,632 120,998 146,629 5.5 25.8 31.3
Allocation per recent prevalence 23,678,994 5,000,248 22,911,520 17,749,574 1,452,211 5,161,947 6,614,158 6.0 21.2 27.1 443,314 323,609 25,632 119,705 145,337 5.5 25.5 31.0
Allocation per projected cases 23,678,994 5,000,248 22,911,520 15,159,537 1,452,211 7,751,983 9,204,194 6.0 31.8 37.8 443,314 277,856 25,632 165,458 191,089 5.5 35.3 40.7
Allocation per projected prevalence 23,678,994 5,000,248 22,911,520 16,106,303 1,452,211 6,805,218 8,257,429 6.0 27.9 33.9 443,314 298,914 25,632 144,400 170,032 5.5 30.8 36.3

CAM: current allocation method; AAM: alternative allocation method